Literature DB >> 27444346

Gegen Qinlian decoction alleviates experimental colitis via suppressing TLR4/NF-κB signaling and enhancing antioxidant effect.

Ruiyan Li1, Yingying Chen2, Meijing Shi1, Xinxin Xu1, Yaxing Zhao1, Xiaojun Wu3, Yubin Zhang4.   

Abstract

BACKGROUND: Gegen Qinlian decoction (GQ), a Chinese medicinal herb decoction, has been widely used as efficient medicine for the treatment of acute colitis in clinics, but underlying molecular mechanisms have not been fully clarified. HYPOTHESIS/
PURPOSE: Inflammation and oxidative stress have been reported to constitute a crucial part in the pathogenesis of ulcerative colitis (UC). Hence, this study was designed to investigate the antiinflammatory activity and antioxidative effect of GQ. STUDY
DESIGN: Mice induced by 5% dextran sulfate sodium (DSS) and macrophage RAW264.7 cells stimulated by lipopolysaccharide (LPS) were used in this study.
METHODS: Ethanol extracts of GQ were orally administered for 1 week on the dosage of 0.3, 1.5, or 7.5g/kg/day and berberine (BBR, 100mg/kg/d) was selected as a positive group in the animal experiments. In vitro, GQ (25, 50, 100µg/ml) or BBR (20µM) co-cultured with RAW264.7 for 2h prior to LPS stimulation.
RESULTS: The results showed that GQ oral administration alleviated the severity of colitis notably. It reduced toll-like receptor 4 (TLR4) expression and NF-κB activation in mucosa, which was accompanied with down regulation of several inflammatory cytokines in the colon, including tumor necrosis factor (TNF-α), interleukin (IL)-6, IL-1β and IL-4. Furthermore, GQ oral administration attenuated the oxidative stress in the colon of UC mice, evidenced by the decrease of myeloperoxidase (MPO) activity and malondialdehyde (MDA) level, and the elevation of glutathione (GSH) content. In parallel with the vivo experiment results, cell research indicated GQ dramatically reduced the production of TNF-α, IL-6, IL-1β and nitric oxide (NO), as well as that of reactive oxygen species (ROS) upon stimulation of LPS.
CONCLUSION: Together, our present study indicates that inhibition of TLR4/NF-κB signaling and enhancement of antioxidant effect might be the potential mechanisms for the therapeutic effect of GQ against UC.
Copyright © 2016 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Antioxidant effect; Gegen Qinlian decoction; NF-κB; TLR4; UC

Mesh:

Substances:

Year:  2016        PMID: 27444346     DOI: 10.1016/j.phymed.2016.06.010

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  22 in total

Review 1.  Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.

Authors:  Shuo Yuan; Qi Wang; Jiao Li; Jia-Chen Xue; You Li; Huan Meng; Xiao-Ting Hou; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Chin Med       Date:  2022-06-18       Impact factor: 4.546

Review 2.  New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.

Authors:  Zezheng Gao; Qingwei Li; Xuemin Wu; Xuemin Zhao; Linhua Zhao; Xiaolin Tong
Journal:  J Immunol Res       Date:  2017-10-15       Impact factor: 4.818

3.  Gegen Qinlian decoction enhances the effect of PD-1 blockade in colorectal cancer with microsatellite stability by remodelling the gut microbiota and the tumour microenvironment.

Authors:  Ji Lv; Yitao Jia; Jing Li; Wentao Kuai; Yang Li; Fang Guo; Xinjian Xu; Zhaolong Zhao; Jian Lv; Zhongxin Li
Journal:  Cell Death Dis       Date:  2019-05-28       Impact factor: 8.469

Review 4.  Targeting NF-κB pathway for treating ulcerative colitis: comprehensive regulatory characteristics of Chinese medicines.

Authors:  Peng-De Lu; Yong-Hua Zhao
Journal:  Chin Med       Date:  2020-02-10       Impact factor: 5.455

5.  Efficacy of herbal medicine (Gegen Qinlian Decoction) on ulcerative colitis: A systematic review of randomized controlled trials.

Authors:  Yuling Fan; Wen Yi; Han Huang; Zhigang Mei; Zhitao Feng
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.817

6.  Inhibitory effects of berberine on proinflammatory M1 macrophage polarization through interfering with the interaction between TLR4 and MyD88.

Authors:  Jing Gong; Jingbin Li; Hui Dong; Guang Chen; Xin Qin; Meilin Hu; Fen Yuan; Ke Fang; Dingkun Wang; Shujun Jiang; Yan Zhao; Wenya Huang; Zhaoyi Huang; Fuer Lu
Journal:  BMC Complement Altern Med       Date:  2019-11-19       Impact factor: 3.659

7.  Molecular Targets and Mechanisms of Scutellariae radix-Coptidis rhizoma Drug Pair for the Treatment of Ulcerative Colitis Based on Network Pharmacology and Molecular Docking.

Authors:  Kai Niu; Qifang Li; Yuan Liu; Yi Qiao; Bingbing Li; Chao Wei; Kunrui Wang; Lu'an Cui; Canlei Zheng; Rong Wang; Li Zhang; Honghua Zhang; Bing Sun; Bin Yu
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-04       Impact factor: 2.629

8.  In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis.

Authors:  Xiaolu Liu; Yuling Fan; Lipeng Du; Zhigang Mei; Yang Fu
Journal:  Front Pharmacol       Date:  2021-06-11       Impact factor: 5.810

9.  S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies.

Authors:  Mohsen Hanifeh; Satu Sankari; Minna M Rajamäki; Pernilla Syrjä; Susanne Kilpinen; Jan S Suchodolski; Romy M Heilmann; Phillip Guadiano; Jonathan Lidbury; Jörg M Steiner; Thomas Spillmann
Journal:  BMC Vet Res       Date:  2018-04-04       Impact factor: 2.741

10.  Network Pharmacology-Based Investigation into the Mechanisms of Quyushengxin Formula for the Treatment of Ulcerative Colitis.

Authors:  Haojie Yang; Ying Li; Sichen Shen; Dan Gan; Changpeng Han; Jiong Wu; Zhenyi Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-12-20       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.